These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15885530)

  • 1. Dermatoglyphics and Schizophrenia: a meta-analysis and investigation of the impact of obstetric complications upon a-b ridge count.
    Bramon E; Walshe M; McDonald C; Martín B; Toulopoulou T; Wickham H; van Os J; Fearon P; Sham PC; Fañanás L; Murray RM
    Schizophr Res; 2005 Jun; 75(2-3):399-404. PubMed ID: 15885530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatoglyphic profile in 22q deletion syndrome.
    Martín B; Fañanás L; Gutiérrez B; Chow EW; Bassett AS
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):46-9. PubMed ID: 15211630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatoglyphics in relation to brain volumes in twins concordant and discordant for bipolar disorder.
    Vonk R; van der Schot AC; van Baal GC; van Oel CJ; Nolen WA; Kahn RS
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1885-95. PubMed ID: 25451699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatoglyphic evidence of fluctuating asymmetry in schizophrenia.
    Mellor CS
    Br J Psychiatry; 1992 Apr; 160():467-72. PubMed ID: 1571744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presentation of dermatoglyphic abnormalities in schizophrenia: a meta-analytic review.
    Golembo-Smith S; Walder DJ; Daly MP; Mittal VA; Kline E; Reeves G; Schiffman J
    Schizophr Res; 2012 Dec; 142(1-3):1-11. PubMed ID: 23116885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of sequential development of dermatoglyphics to schizophrenia.
    Ponnudurai R
    Psychiatry Res; 1999 Dec; 89(1):59-67. PubMed ID: 10643878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cerebral structural abnormalities and dermatoglyphic ridge counts in schizophrenia.
    van Os J; Woodruff PW; Fañanas L; Ahmad F; Shuriquie N; Howard R; Murray RM
    Compr Psychiatry; 2000; 41(5):380-4. PubMed ID: 11011835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatoglyphic indices and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non psychiatric controls.
    Gabalda MK; Compton MT
    Psychiatry Res; 2010 Jul; 178(2):255-9. PubMed ID: 20478629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological soft signs and dermatoglyphic anomalies in twins with schizophrenia.
    Kelly BD; Cotter D; Denihan C; Larkin D; Murphy P; Kinsella A; Walsh D; Waddington J; Larkin C; O'Callaghan E; Lane A
    Eur Psychiatry; 2004 May; 19(3):159-63. PubMed ID: 15158923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New evidences of gene and environment interactions affecting prenatal neurodevelopment in schizophrenia-spectrum disorders: a family dermatoglyphic study.
    Fatjó-Vilas M; Gourion D; Campanera S; Mouaffak F; Levy-Rueff M; Navarro ME; Chayet M; Miret S; Krebs MO; Fañanás L
    Schizophr Res; 2008 Aug; 103(1-3):209-17. PubMed ID: 18583099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: replication in two samples.
    Fañanas L; van Os J; Hoyos C; McGrath J; Mellor CS; Murray R
    Schizophr Res; 1996 Jul; 20(3):307-14. PubMed ID: 8827858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is reduced dermatoglyphic a-b ridge count a reliable marker of developmental impairment in schizophrenia?
    Fearon P; Lane A; Airie M; Scannell J; McGowan A; Byrne M; Cannon M; Cotter D; Murphy P; Cassidy B; Waddington J; Larkin C; O'Callaghan E
    Schizophr Res; 2001 Jul; 50(3):151-7. PubMed ID: 11439235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical stigmata of aberrant neurodevelopment in schizophrenia.
    Buckley PF
    J Nerv Ment Dis; 1998 Feb; 186(2):79-86. PubMed ID: 9484307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative dermatoglyphic study of schizophrenic patients: evidence of the neurodevelopmental model of schizophrenia.
    Sivkov ST; Akabaliev VH; Kaleva NN
    Folia Med (Plovdiv); 2009; 51(3):25-30. PubMed ID: 19957559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study.
    O'Callaghan E; Gibson T; Colohan HA; Buckley P; Walshe DG; Larkin C; Waddington JL
    BMJ; 1992 Nov; 305(6864):1256-9. PubMed ID: 1477568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal head circumference and related indices of disturbed fetal development in schizophrenic patients.
    Cantor-Graae E; Ismail B; McNeil TF
    Schizophr Res; 1998 Aug; 32(3):191-9. PubMed ID: 9720124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-trimester markers of fetal size in schizophrenia: a study of monozygotic twins.
    Bracha HS; Torrey EF; Gottesman II; Bigelow LB; Cunniff C
    Am J Psychiatry; 1992 Oct; 149(10):1355-61. PubMed ID: 1530072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatoglyphic correlates of hippocampus volume: Evaluation of aberrant neurodevelopmental markers in antipsychotic-naïve schizophrenia.
    Kalmady SV; Shivakumar V; Gautham S; Arasappa R; Jose DA; Venkatasubramanian G; Gangadhar BN
    Psychiatry Res; 2015 Oct; 234(1):113-20. PubMed ID: 26385539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic loadings in schizophrenia: a dermatoglyphic study.
    Balgir RS; Murthy RS; Wig NN
    Isr J Med Sci; 1993 May; 29(5):265-8. PubMed ID: 8314683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative dermatoglyphics in schizophrenia: study of family history subgroups.
    Fañanás L; Moral P; Bertranpetit J
    Hum Biol; 1990 Jun; 62(3):421-7. PubMed ID: 2373511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.